Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Single-Arm Study of Atezolizumab Monotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Clinical Evaluation of Novel Blood-Based Diagnostics

NCT02848651 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT02848651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02848651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Single-Arm Study of Atezolizumab Monotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Clinical Evaluation of Novel Blood-Based Diagnostics
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 23, 2016
Completion date
May 14, 2019
Enrollment
153 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer